Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 3089

1.

Social participation reduces isolation among Japanese older people in urban area: A 3-year longitudinal study.

Ejiri M, Kawai H, Fujiwara Y, Ihara K, Watanabe Y, Hirano H, Kim HK, Ishii K, Oka K, Obuchi S.

PLoS One. 2019 Sep 20;14(9):e0222887. doi: 10.1371/journal.pone.0222887. eCollection 2019.

PMID:
31539403
2.

A Prospective Study Evaluating the Clinical Utility of the Tag-Less Patency Capsule with Extended Time for Confirming Functional Patency.

Watanabe K, Ohmiya N, Nakamura M, Fujiwara Y.

Digestion. 2019 Sep 19:1-8. doi: 10.1159/000503027. [Epub ahead of print]

PMID:
31536998
3.

SARC-F: A validation study with community-dwelling older Japanese adults.

Kera T, Kawai H, Hirano H, Kojima M, Watanabe Y, Motokawa K, Fujiwara Y, Ihara K, Kim H, Obuchi S.

Geriatr Gerontol Int. 2019 Sep 18. doi: 10.1111/ggi.13768. [Epub ahead of print]

PMID:
31535433
4.

Correction: Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma.

Ohmoto A, Suzuki M, Takai E, Rokutan H, Fujiwara Y, Morizane C, Yanagihara K, Shibata T, Yachida S.

Oncotarget. 2019 Sep 10;10(52):5494. doi: 10.18632/oncotarget.27199. eCollection 2019 Sep 10.

5.

Prognostic Significance of Pre- and Post-operative Red-Cell Distribution Width in Patients with Gastric Cancer.

Shota S, Saito H, Kono Y, Murakami Y, Shishido Y, Miyatani K, Matsunaga T, Fukumoto Y, Fujiwara Y.

J Gastrointest Surg. 2019 Sep 16. doi: 10.1007/s11605-019-04392-w. [Epub ahead of print]

PMID:
31529200
6.

Assessment of Outcome of Hepatic Resection for Extremely Elderly Patients With a Hepatic Malignancy.

Horiuchi T, Haruki K, Shiba H, Sakamoto T, Saito N, Shirai Y, Iwase R, Fujiwara Y, Yanaga K.

Anticancer Res. 2019 Sep;39(9):5143-5148. doi: 10.21873/anticanres.13709.

PMID:
31519626
7.

Long-term outcomes of preoperative docetaxel with cisplatin plus S-1 therapy for gastric cancer with extensive nodal metastasis (JCOG1002).

Takahari D, Ito S, Mizusawa J, Katayama H, Terashima M, Sasako M, Morita S, Nomura T, Yamada M, Fujiwara Y, Kimura Y, Ikeda A, Kadokawa Y, Sano T; Stomach Cancer Study Group of the Japan Clinical Oncology Group.

Gastric Cancer. 2019 Sep 12. doi: 10.1007/s10120-019-01007-w. [Epub ahead of print]

PMID:
31515693
8.

Recommendations for promoting international multi-site clinical trials-from a viewpoint of ethics review.

Nakada H, Hasthorpe S, IJsselmuiden C, Kombe F, Ba M, Matei M, Nakamura K, Ushirozawa N, Fujiwara Y, Tashiro S.

Dev World Bioeth. 2019 Sep 12. doi: 10.1111/dewb.12245. [Epub ahead of print] No abstract available.

PMID:
31513337
9.

Increased regulatory B cells are involved in immune evasion in patients with gastric cancer.

Murakami Y, Saito H, Shimizu S, Kono Y, Shishido Y, Miyatani K, Matsunaga T, Fukumoto Y, Ashida K, Sakabe T, Nakayama Y, Fujiwara Y.

Sci Rep. 2019 Sep 11;9(1):13083. doi: 10.1038/s41598-019-49581-4.

10.

Individual optimal dose of amrubicin to prevent severe neutropenia in Japanese patients with lung cancer.

Makino Y, Makihara-Ando R, Ogawa T, Sato H, Goto Y, Kanda S, Horinouchi H, Fujiwara Y, Ohe Y, Yamamoto N.

Cancer Sci. 2019 Sep 10. doi: 10.1111/cas.14194. [Epub ahead of print]

11.

Prognostic significance of platelet × C-reactive protein multiplier in patients with esophageal squamous cell carcinoma.

Shishido Y, Saito H, Shimizu S, Kono Y, Murakami Y, Miyatani K, Matsunaga T, Yamamoto M, Fukumoto Y, Honjo S, Fujiwara Y.

Surg Today. 2019 Aug 30. doi: 10.1007/s00595-019-01865-y. [Epub ahead of print]

PMID:
31471746
12.

Low-carbohydrate diet by staple change attenuates postprandial GIP and CPR levels in type 2 diabetes patients.

Kondo-Ando M, Seino Y, Morikawa R, Negi K, Todoroki H, Kawakami T, Asada Y, Yoshimoto R, Tanaka C, Okamoto K, Masuda A, Tomatsu E, Hiratsuka I, Yoshino Y, Maki W, Kakita A, Shibata M, Takayanagi T, Makino M, Sugimura Y, Asai S, Ito A, Ueno S, Fujiwara Y, Kuwata H, Yabe D, Suzuki A.

J Diabetes Complications. 2019 Aug 15:107415. doi: 10.1016/j.jdiacomp.2019.107415. [Epub ahead of print]

PMID:
31466840
13.

Efficacy and safety of crizotinib in patients with ROS1 rearranged non-small cell lung cancer: a retrospective analysis.

Masuda K, Fujiwara Y, Shinno Y, Mizuno T, Sato J, Morita R, Matsumoto Y, Murakami S, Goto Y, Kanda S, Horinouchi H, Yamamoto N, Ohe Y.

J Thorac Dis. 2019 Jul;11(7):2965-2972. doi: 10.21037/jtd.2019.07.44.

14.

The time course of dysphagia following traumatic cervical spinal cord injury: a prospective cohort study.

Hayashi T, Fujiwara Y, Sakai H, Kubota K, Kawano O, Mori E, Takao T, Masuda M, Morishita Y, Maeda T.

Spinal Cord. 2019 Aug 28. doi: 10.1038/s41393-019-0347-4. [Epub ahead of print]

PMID:
31462759
15.

Phase I safety and pharmacokinetics study of rovalpituzumab tesirine in Japanese patients with advanced, recurrent small cell lung cancer.

Udagawa H, Akamatsu H, Tanaka K, Takeda M, Kanda S, Kirita K, Teraoka S, Nakagawa K, Fujiwara Y, Yasuda I, Okubo S, Shintani M, Kosloski MP, Scripture C, Tamura T, Okamoto I.

Lung Cancer. 2019 Sep;135:145-150. doi: 10.1016/j.lungcan.2019.07.025. Epub 2019 Jul 24.

PMID:
31446987
16.

Significance of FLT3-tyrosine kinase domain mutation as a prognostic factor for acute myeloid leukemia.

Sakaguchi M, Yamaguchi H, Kuboyama M, Najima Y, Usuki K, Ueki T, Oh I, Mori S, Kawata E, Uoshima N, Kobayashi Y, Kako S, Tajika K, Shono K, Kayamori K, Hagihara M, Kanda J, Uchiyama H, Kuroda J, Uchida N, Kubota Y, Kimura S, Kurosawa S, Date K, Nakajima N, Marumo A, Omori I, Fujiwara Y, Terada K, Yui S, Wakita S, Arai K, Kitano T, Kakihana K, Kanda Y, Ohashi K, Fukuda T, Inokuchi K.

Int J Hematol. 2019 Aug 20. doi: 10.1007/s12185-019-02720-z. [Epub ahead of print]

PMID:
31432396
17.

Anti-stress effects of the hydroalcoholic extract of Rosa gallica officinalis in mice.

Ueno H, Shimada A, Suemitsu S, Murakami S, Kitamura N, Wani K, Matsumoto Y, Okamoto M, Fujiwara Y, Ishihara T.

Heliyon. 2019 Jun 14;5(6):e01945. doi: 10.1016/j.heliyon.2019.e01945. eCollection 2019 Jun.

18.

Comparison of Radiographic Progression-Free Survival and PSA Response on Sequential Treatment Using Abiraterone and Enzalutamide for Newly Diagnosed Castration-Resistant Prostate Cancer: A Propensity Score Matched Analysis from Multicenter Cohort.

Komura K, Fujiwara Y, Uchimoto T, Saito K, Tanda N, Matsunaga T, Ichihashi A, Tsutsumi T, Tsujino T, Yoshikawa Y, Nishimoto Y, Takai T, Minami K, Taniguchi K, Tanaka T, Uehara H, Hirano H, Nomi H, Ibuki N, Takahara K, Inamoto T, Azuma H.

J Clin Med. 2019 Aug 19;8(8). pii: E1251. doi: 10.3390/jcm8081251.

19.

Treatment Outcomes of Burr-Hole Surgery for Chronic Subdural Hematoma in the Elderly Living Beyond Life Expectancy: A Study Comparing Cure, Recurrence, and Complications in Patients Aged ≥80 Years versus ≤79 Years.

Watanabe S, Kato N, Sato M, Aiyama H, Fujiwara Y, Goto M, Yamazaki T, Yasuda S, Ishikawa E, Matsumura A.

World Neurosurg. 2019 Aug 9. pii: S1878-8750(19)32155-2. doi: 10.1016/j.wneu.2019.08.003. [Epub ahead of print]

PMID:
31404689
20.

Endoscopic closure using polyglycolic acid sheets for delayed perforation after colonic endoscopic submucosal dissection.

Nagami Y, Fukunaga S, Kanamori A, Sakai T, Ominami M, Watanabe T, Fujiwara Y.

Endoscopy. 2019 Aug 9. doi: 10.1055/a-0978-4501. [Epub ahead of print] No abstract available.

PMID:
31398745
21.

The postoperative platelet distribution width is useful for predicting the prognosis in patients with esophageal squamous cell carcinoma.

Matsunaga T, Saito H, Fukumoto Y, Shimizu S, Kono Y, Murakami Y, Shishido Y, Miyatani K, Yamamoto M, Tokuyasu N, Takano S, Sakamoto T, Honjo S, Fujiwara Y.

Surg Today. 2019 Aug 6. doi: 10.1007/s00595-019-01860-3. [Epub ahead of print]

PMID:
31388825
22.

Comparison of the intracorporeal triangular and delta-shaped anastomotic techniques in totally laparoscopic distal gastrectomy for gastric cancer: an analysis with propensity score matching.

Yanagimoto Y, Omori T, Fujiwara Y, Demura K, Jeong-Ho M, Shinno N, Yamamoto K, Sugimura K, Miyata H, Ushigome H, Takahashi Y, Nishimura J, Yasui M, Asukai K, Yamada D, Wada H, Takahashi H, Ohue M, Yano M, Sakon M.

Surg Endosc. 2019 Aug 5. doi: 10.1007/s00464-019-07025-0. [Epub ahead of print]

PMID:
31385072
23.

Gene Alterations in Triple-Negative Breast Cancer Patients in a Phase I/II Study of Eribulin and Olaparib Combination Therapy.

Shimomura A, Yonemori K, Yoshida M, Yoshida T, Yasojima H, Masuda N, Aogi K, Takahashi M, Naito Y, Shimizu S, Nakamura R, Hamada A, Michimae H, Hashimoto J, Yamamoto H, Kawachi A, Shimizu C, Fujiwara Y, Tamura K.

Transl Oncol. 2019 Aug 2;12(10):1386-1394. doi: 10.1016/j.tranon.2019.07.013. [Epub ahead of print]

24.

Gene expression profiles in the dorsal root ganglia of methylmercury-exposed rats.

Shinoda Y, Tatsumi S, Yoshida E, Takahashi T, Eto K, Kaji T, Fujiwara Y.

J Toxicol Sci. 2019;44(8):549-558. doi: 10.2131/jts.44.549.

25.

Diagnosis of fast ions produced by negative-ion neutral-beam injection with fast-ion deuterium-alpha spectroscopy.

Muscatello CM, Heidbrink WW, Boivin RL, Chrystal C, Collins CS, Fujiwara Y, Yamaguchi H.

Rev Sci Instrum. 2019 Jul;90(7):073504. doi: 10.1063/1.5099491.

PMID:
31370451
26.

Prognostic Value of DEPDC1 Expression in Tumor and Non-tumor Tissue of Patients With Hepatocellular Carcinoma.

Amisaki M, Yagyu T, Uchinaka EI, Morimoto M, Hanaki T, Watanabe J, Tokuyasu N, Sakamoto T, Honjo S, Fujiwara Y.

Anticancer Res. 2019 Aug;39(8):4423-4430. doi: 10.21873/anticanres.13614.

PMID:
31366540
27.

Hearing Impairment and Prevalence of Mild Cognitive Impairment in Japan: Baseline Data From the Aidai Cohort Study in Yawatahama and Uchiko.

Miyake Y, Tanaka K, Senba H, Ogawa S, Suzuki H, Fujiwara Y, Okada M, Takagi D, Teraoka M, Yamada H, Nobuhara T, Matsuura B, Hato N.

Ear Hear. 2019 Jul 25. doi: 10.1097/AUD.0000000000000773. [Epub ahead of print]

PMID:
31356389
28.

Albumin and Hemoglobin Trajectories and Incident Disabling Dementia in Community-Dwelling Older Japanese.

Taniguchi Y, Kitamura A, Kaito S, Yokoyama Y, Yokota I, Shinozaki T, Seino S, Murayama H, Matsuyama Y, Ikeuchi T, Fujiwara Y, Shinkai S.

Dement Geriatr Cogn Disord. 2019 Jul 17:1-10. doi: 10.1159/000499837. [Epub ahead of print]

PMID:
31315125
29.

Accurate expression of PD-L1/L2 in lung adenocarcinoma cells: A retrospective study by double immunohistochemistry.

Shinchi Y, Komohara Y, Yonemitsu K, Sato K, Ohnishi K, Saito Y, Fujiwara Y, Mori T, Shiraishi K, Ikeda K, Suzuki M.

Cancer Sci. 2019 Sep;110(9):2711-2721. doi: 10.1111/cas.14128. Epub 2019 Jul 31.

30.

Relationship between diet/exercise and pharmacotherapy to enhance the GLP-1 levels in type 2 diabetes.

Fujiwara Y, Eguchi S, Murayama H, Takahashi Y, Toda M, Imai K, Tsuda K.

Endocrinol Diabetes Metab. 2019 May 16;2(3):e00068. doi: 10.1002/edm2.68. eCollection 2019 Jul. Review.

31.

Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition.

Mishima S, Taniguchi H, Akagi K, Baba E, Fujiwara Y, Hirasawa A, Ikeda M, Maeda O, Muro K, Nishihara H, Nishiyama H, Takano T, Tsuchihara K, Yatabe Y, Kodera Y, Yoshino T.

Int J Clin Oncol. 2019 Jul 8. doi: 10.1007/s10147-019-01498-8. [Epub ahead of print]

PMID:
31286289
32.

Association between decrease in frequency of going out and oral function in older adults living in major urban areas.

Mikami Y, Watanabe Y, Motokawa K, Shirobe M, Motohashi Y, Edahiro A, Nakajima J, Osuka Y, Inagaki H, Fujiwara Y, Shinkai S, Awata S.

Geriatr Gerontol Int. 2019 Aug;19(8):792-797. doi: 10.1111/ggi.13715. Epub 2019 Jul 2.

PMID:
31267649
33.

Induction of chemokine CCL3 by NF-κB reduces methylmercury toxicity in C17.2 mouse neural stem cells.

Takahashi T, Kim MS, Iwai-Shimada M, Hoshi T, Fujimura M, Toyama T, Fujiwara Y, Naganuma A, Hwang GW.

Environ Toxicol Pharmacol. 2019 Oct;71:103216. doi: 10.1016/j.etap.2019.103216. Epub 2019 Jun 24.

PMID:
31260942
34.

A minimum of 100 tumor cells in a single biopsy sample is required to assess programmed cell death ligand 1 expression in predicting patient response to nivolumab treatment in non-squamous non-small cell lung carcinoma.

Naito T, Udagawa H, Sato J, Horinouchi H, Murakami S, Goto Y, Kanda S, Fujiwara Y, Yamamoto N, Zenke Y, Kirita K, Matsumoto S, Yoh K, Niho S, Motoi N, Ohe Y, Ishii G, Goto K.

J Thorac Oncol. 2019 Jun 28. pii: S1556-0864(19)30501-5. doi: 10.1016/j.jtho.2019.06.019. [Epub ahead of print]

PMID:
31260834
35.

Rational targeting of a NuRD subcomplex guided by comprehensive in situ mutagenesis.

Sher F, Hossain M, Seruggia D, Schoonenberg VAC, Yao Q, Cifani P, Dassama LMK, Cole MA, Ren C, Vinjamur DS, Macias-Trevino C, Luk K, McGuckin C, Schupp PG, Canver MC, Kurita R, Nakamura Y, Fujiwara Y, Wolfe SA, Pinello L, Maeda T, Kentsis A, Orkin SH, Bauer DE.

Nat Genet. 2019 Jul;51(7):1149-1159. doi: 10.1038/s41588-019-0453-4. Epub 2019 Jun 28.

PMID:
31253978
36.

[Effects of an interprofessional educational program for homecare professionals on building social capital: a trial in an urban area].

Murayama H, Komiyama E, Hirahara S, Nonaka K, Iijima K, Fujiwara Y.

Nihon Koshu Eisei Zasshi. 2019;66(6):317-326. doi: 10.11236/jph.66.6_317. Japanese.

37.

Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumors.

Doi T, Fujiwara Y, Matsubara N, Tomomatsu J, Iwasa S, Tanaka A, Endo-Tsukude C, Nakagawa S, Takahashi S.

Cancer Chemother Pharmacol. 2019 Aug;84(2):393-404. doi: 10.1007/s00280-019-03882-7. Epub 2019 Jun 21.

38.

[Influence of Bowtie Filter and Patient Positioning on In-plane Dose Distribution and Image Quality in ECG-gated CT].

Minami K, Matsubara K, Hayashi Y, Fujiwara Y, Morimoto K, Kobatake T.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2019;75(6):536-545. doi: 10.6009/jjrt.2019_JSRT_75.6.536. Japanese.

39.

Multiple osteolytic bone and lung metastases from prostate cancer including small cell carcinoma with marked increases in CEA and Pro-GRP.

Okamura S, Fujiwara Y, Nagata K.

Urol Case Rep. 2019 Mar 26;24:100883. doi: 10.1016/j.eucr.2019.100883. eCollection 2019 May.

40.

Impact of Age on Long-Term Survival in Patients with Esophageal Cancer Who Underwent Transthoracic Esophagectomy.

Motoori M, Ito Y, Miyashiro I, Sugimura K, Miyata H, Omori T, Fujiwara Y, Yano M.

Oncology. 2019;97(3):149-154. doi: 10.1159/000500604. Epub 2019 Jun 13.

PMID:
31195394
41.

Phase I study of BGT226, a pan-PI3K and mTOR inhibitor, in Japanese patients with advanced solid cancers.

Minami H, Fujiwara Y, Muro K, Sato M, Moriya A.

Cancer Chemother Pharmacol. 2019 Aug;84(2):337-343. doi: 10.1007/s00280-019-03883-6. Epub 2019 Jun 12.

PMID:
31190275
42.

Large Skin Ulcer and Delayed Wound Healing around a Colostomy in a Patient with Metastatic Colorectal Cancer Receiving Vascular Endothelial Growth Factor Receptor-2 Inhibitor Therapy.

Taira K, Nadatani Y, Hirano S, Maeda K, Fujiwara Y.

Case Rep Oncol. 2019 May 16;12(2):370-375. doi: 10.1159/000500412. eCollection 2019 May-Aug.

43.

Difference in central nerve system metastasis during gefitinib or erlotinib therapy in patients with EGFR-mutated non-small cell lung cancer: a retrospective study.

Yoshida K, Kanda S, Shiraishi H, Goto K, Itahashi K, Goto Y, Horinouchi H, Fujiwara Y, Nokihara H, Yamamoto N, Ohe Y.

J Thorac Dis. 2019 Apr;11(4):1347-1354. doi: 10.21037/jtd.2019.03.61.

44.

[Current knowledge of mechanisms of drugs-induced gastrointestinal damage].

Watanabe T, Fujiwara Y.

Nihon Shokakibyo Gakkai Zasshi. 2019;116(6):468-478. doi: 10.11405/nisshoshi.116.468. Japanese. No abstract available.

PMID:
31178576
45.

Transabdominal preperitoneal repair for an adolescent patient with Hunter syndrome: a case report.

Tada Y, Yamamoto M, Sunaguchi T, Uejima C, Tanio A, Murakami Y, Takano S, Sakamoto T, Honjo S, Ashida K, Saito H, Fujiwara Y.

Surg Case Rep. 2019 May 31;5(1):89. doi: 10.1186/s40792-019-0645-2.

46.

Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma.

Kuorda H, Abe T, Fujiwara Y, Okamoto T, Yonezawa M, Sato H, Endo K, Oikawa T, Sawara K, Takikawa Y.

World J Gastroenterol. 2019 May 21;25(19):2365-2372. doi: 10.3748/wjg.v25.i19.2365.

47.

The prognostic significance of the comprehensive complication index in patients with gastric cancer.

Shimizu S, Saito H, Kono Y, Murakami Y, Shishido Y, Miyatani K, Matsunaga T, Fukumoto Y, Fujiwara Y.

Surg Today. 2019 May 30. doi: 10.1007/s00595-019-01828-3. [Epub ahead of print]

PMID:
31147763
48.

Phase I study of the indoleamine 2,3-dioxygenase 1 inhibitor navoximod (GDC-0919) as monotherapy and in combination with the PD-L1 inhibitor atezolizumab in Japanese patients with advanced solid tumours.

Ebata T, Shimizu T, Fujiwara Y, Tamura K, Kondo S, Iwasa S, Yonemori K, Shimomura A, Kitano S, Koyama T, Sato N, Nakai K, Inatani M, Yamamoto N.

Invest New Drugs. 2019 May 24. doi: 10.1007/s10637-019-00787-3. [Epub ahead of print]

PMID:
31124055
49.

Have We Found the Key to Unravel Treatment Development Lags for Rare Cancers?: MASTER KEY Project.

Okuma HS, Fujiwara Y.

Clin Pharmacol Ther. 2019 Sep;106(3):491-492. doi: 10.1002/cpt.1453. Epub 2019 May 23. No abstract available.

PMID:
31121054
50.

Azathioprine Is Useful for Maintaining Long-term Remission Induced by Tacrolimus for the Treatment of Ulcerative Colitis: An Inverse Probability of a Treatment Weighing Analysis.

Nishida Y, Hosomi S, Yamagami H, Sugita N, Itani S, Yukawa T, Otani K, Nagami Y, Tanaka F, Taira K, Kamata N, Kakimoto K, Tanigawa T, Watanabe T, Fujiwara Y.

Intern Med. 2019 Aug 15;58(16):2305-2313. doi: 10.2169/internalmedicine.2632-19. Epub 2019 May 22.

Supplemental Content

Loading ...
Support Center